Early Palliative Care Can Lessen Hospital Stays, Improve Well-Being
It is never too early for a patient diagnosed with mesothelioma — or most any cancer — to start consulting with a palliative care specialist, according to a recent study. The message from researchers at the University of Texas MD Anderson Cancer Center in Houston: The sooner, the better. Results from the study show early palliative care referrals and outpatient referrals were associated with fewer hospitalizations, emergency room visits, intensive-care admissions and hospital deaths compared to those on an inpatient basis. Palliative care focuses on pain relief, symptom reduction and quality of life improvement, and it’s usually recommended for patients with a poor diagnosis or a late-stage cancer. David Hui, M.D., oncologist at MD Anderson Cancer Center and one of the study’s authors, told Asbestos.com that palliative care is often neglected or delayed, unnecessarily depriving cancer patients of valuable and available resources, researchers said. "Earlier palliative care is generally a good thing," said Hui, who is also one of the nation's leaders in palliative care research. "There is more and more evidence to support the need for it, and the benefits that come from it." Study Revealed Significant Differences Researchers published the study titled, “Early outpatient referral to palliative care services improves end-of-life care,” in the July/August edition of CA: A Cancer Journal for Clinicians. The study included 36...
Authors: Kim SE, Lee SJ, Cha JY, Yi SW, Kim TS, Cho IL, Kwak JY, Oh KH Abstract Colon cancer is very rarely accompanied by tumor thrombosis of the superior mesenteric vein (SMV). A 46-year-old patient had been diagnosed with SMV tumor thrombosis related to colon cancer without hepatic metastasis and underwent right hemicolectomy with SMV tumor thrombectomy. Tumor thrombosis was pathologically confirmed as metastatic colon cancer. There has been no recurrence for 12 months with 12 cycles of adjuvant-chemotherapy. PMID: 30992420 [PubMed - as supplied by publisher]
Publication date: Available online 17 April 2019Source: The Journal of Molecular DiagnosticsAuthor(s): Emily B. Hollister, Numan Oezguen, Bruno P. Chumpitazi, Ruth Ann Luna, Erica M. Weidler, Michelle Rubio-Gonzales, Mahmoud Dahdouli, Julia L. Cope, Toni-Ann Mistretta, Sabeen Raza, Ginger A. Metcalf, Donna M. Muzny, Richard A. Gibbs, Joseph F. Petrosino, Margaret Heitkemper, Tor C. Savidge, Robert J. Shulman, James VersalovicAccurate diagnosis and stratification of children with irritable bowel syndrome (IBS) remain challenging. Given the central role of recurrent abdominal pain in IBS, we evaluated the relationships of pe...
Publication date: Available online 18 April 2019Source: Pathology - Research and PracticeAuthor(s): Xiao-Jie Chen, Ya-Qin Tan, Na Zhang, Ming-Jing He, Gang ZhouAbstractObjectiveIn recent years, monoclonal antibodies targeting programmed cell death-ligand 1 (PD-L1) have become a promising cancer immunotherapy. However, the role of PD-L1 in oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs), including oral leukoplakia (OLK), remains controversial. The aim of the present study was to investigate the expression level of PD-L1 in OSCC and OPMDs, and examine its relationship with CD8 expression ...
In conclusion, our findings indicate that targeting miR-142-5p may provide a novel strategy for the treatment of pancreatic cancer.
Conclusions: Our study demonstrated that TRIP13 might be a tumor promoting factor in ESCC and a promising prognostic indicator for ESCC patient.
In conclusion, B7-H3 could be a target of bone cancers.
ConclusionCircRNAs have high sensitivity and specificity in the diagnosis of gastric cancer, and it may become an auxiliary diagnostic biomarker of gastric cancer.
This study aimed to investigate the role and regulatory mechanism of CypB in NSCLC progression. The expression levels of CypB was detected in NSCLC samples and cell lines by ELISA, western blot and immunohistochemistry assay. In addition, CCK8, colony formation, scratch and transwell assays were used to evaluate the proliferation, migration and invasion of A549 cells with CypB silencing. The expression of angiogenesis related proteins and pathway-related factors were detected by western blot. In NSCLC samples, CypB expression was upregulated. The expression of CypB was significantly reduced in the siRNA-cyclophilin B group...
ConclusionMetallosis-associated osteolysis should be suspected in cases with radiologically evident polyethylene wear after knee replacement. Recognizing that revision arthroplasty is very technically demanding in such cases, surgeons should have a back-up with modular revision components and a ready access to reconstructive options at this revision setting.
Conclusions: FMF rarely involves the posterior pole. Visual loss in FMF results from either posterior scleritis or posterior uveitis. A high degree of suspicion of posterior scleritis is warranted in female patients with known FMF presenting with cloudy serous macular detachment.Case Rep Ophthalmol 2019;10:134 –139
More News: Asbestosis | Cancer | Cancer & Oncology | Cancer Therapy | Clinical Trials | Depression | Emergency Medicine | Environmental Health | Hospital Management | Hospitals | Intensive Care | Men | Mesothelioma | Nurses | Nursing | Pain | Pain Management | Palliative | Palliative Care | Psychology | Study | Texas University